Trial intelligence / Profile preview

Pharmacokinetics of linezolid in dialysis

2006-002338-39Phase 4Completed

Sponsor
Heidelberg University Hospital
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of linezolid in acute kidney failure (AKF), sepsis and Infection (2 arms), sponsored by Heidelberg University Hospital. Primary endpoints: Pharmacokinetic parameters of linezolid under dialysis and Influence of sepsis without dialysis on linezolid pharmacokinetics. Started Aug 2006; status: completed.

02

Drugs

linezolid
03

Conditions

acute kidney failure (AKF)sepsisInfection

Beyond the preview

Go deeper on 2006-002338-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002338-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call